National Institute of Mental Health; Notice of Meeting, 61694 [E9-28284]

Download as PDF 61694 Federal Register / Vol. 74, No. 226 / Wednesday, November 25, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting sroberts on DSKD5P82C1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Autism Coordinating Committee (IACC) meeting. The purpose of the IACC meeting is to continue discussing recommendations for the annual update of the IACC Strategic Plan for Autism Spectrum Disorders Research. The IACC meeting will be conducted and available to the public via a telephone conference call and a webinar. Name of Committee: Interagency Autism Coordinating Committee (IACC) Type of meeting: Open meeting via conference call and webinar only; no inperson meeting. Date: December 11, 2009. Time: 9 a.m. to 1 p.m.* Eastern Time—* Approximate end time. Meeting Registration: No registration is required to listen to the conference call or view the webinar. Agenda: To continue discussion on recommendations for the annual update of the IACC Strategic Plan for Autism Spectrum Disorder Research. Webinar: https://www2.gotomeeting.com/ register/906979171. Conference Call Access: Dial: 888–455– 2920. Access code: 9984461. Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, Office of the Director, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 8200, Bethesda, MD 20892–9669, Phone: (301) 443–6040, E-mail: IACCPublicInquiries@mail.nih.gov. Any interested person may submit written comments to the IACC prior to the meeting by sending the statement to the Contact Person listed on this notice by 5 p.m. ET on December 8, 2009. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. All written statements received by the deadline will be provided to the IACC for their consideration. The meeting will be open to the public through a conference call phone number and a webinar conducted using a web presentation tool on the Internet. Individuals who participate using this service and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the contact person listed above at least seven days prior to the meeting. If you experience any technical problems with the Web presentation tool or conference call, please e-mail IACCTechSupport@acclaroresearch.com. Members of the public who participate using the conference call phone number will VerDate Nov<24>2008 17:36 Nov 24, 2009 Jkt 220001 be able to listen to the meeting but will not be heard. This phone call may end prior to or later than 1 p.m., depending on the needs of the Committee. To access the webinar on the Internet the following computer capabilities are required: (A) Internet Explorer 5.0 or later, Netscape Navigator 6.0 or later or Mozilla Firefox 1.0 or later; (B) Windows® 2000, XP Home, XP Pro, 2003 Server or Vista; (C) Stable 56k, cable modem, ISDN, DSL or better Internet connection; (D) Minimum of Pentium 400 with 256 MB of RAM (Recommended); (E) Java Virtual Machine enabled (Recommended) This meeting is being published less than 15 days prior to the meeting due to the timing limitations for completing the updating of the Annual Strategic Plan for Autism Spectrum Disorder Research. Information about the IACC is available on the Web site: https://www.iacc.hhs.gov. Meeting schedule subject to change. Dated: November 19, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–28284 Filed 11–24–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Clinical Trial Grant Review. Date: December 8, 2009. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Eric H. Brown, PhD, Scientific Review Officer, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Democracy Blvd., Room 824, Msc 4872, Bethesda, MD 20892–4872, (301) 594– 4955,browneri@mail.nih.gov. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Providing Radiologic Outcomes for the Osteoarthritis Initiative. Date: December 16, 2009. Time: 10 a.m. to 11:30 a.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Charles N. Rafferty, PhD, Chief, Review Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 Democracy Boulevard, Suite 800, Bethesda, MD 20817, 301–534–4952, raffertycn@mail.nih.gov. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Clinical Outcome Instrument Development. Date: January 26, 2010. Time: 8 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Michael L. Bloom, PhD., MBA, Scientific Review Officer, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 Democracy Blvd.; Room 820, MSC 4872, Bethesda, MD 20892–4872, 301–594– 4953, Michael_Bloom@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) Dated: November 19, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–28289 Filed 11–24–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and E:\FR\FM\25NON1.SGM 25NON1

Agencies

[Federal Register Volume 74, Number 226 (Wednesday, November 25, 2009)]
[Notices]
[Page 61694]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-28284]



[[Page 61694]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of an Interagency 
Autism Coordinating Committee (IACC) meeting.
    The purpose of the IACC meeting is to continue discussing 
recommendations for the annual update of the IACC Strategic Plan for 
Autism Spectrum Disorders Research. The IACC meeting will be conducted 
and available to the public via a telephone conference call and a 
webinar.

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC)
    Type of meeting: Open meeting via conference call and webinar 
only; no in-person meeting.
    Date: December 11, 2009.
    Time: 9 a.m. to 1 p.m.* Eastern Time--* Approximate end time.
    Meeting Registration: No registration is required to listen to 
the conference call or view the webinar.
    Agenda: To continue discussion on recommendations for the annual 
update of the IACC Strategic Plan for Autism Spectrum Disorder 
Research.
    Webinar: https://www2.gotomeeting.com/register/906979171.
    Conference Call Access: Dial: 888-455-2920. Access code: 
9984461.
    Contact Person: Ms. Lina Perez, Office of Autism Research 
Coordination, Office of the Director, National Institute of Mental 
Health, NIH, 6001 Executive Boulevard, NSC, Room 8200, Bethesda, MD 
20892-9669, Phone: (301) 443-6040, E-mail: 
IACCPublicInquiries@mail.nih.gov.

    Any interested person may submit written comments to the IACC 
prior to the meeting by sending the statement to the Contact Person 
listed on this notice by 5 p.m. ET on December 8, 2009. The 
statement should include the name, address, telephone number and 
when applicable, the business or professional affiliation of the 
interested person. All written statements received by the deadline 
will be provided to the IACC for their consideration.
    The meeting will be open to the public through a conference call 
phone number and a webinar conducted using a web presentation tool 
on the Internet. Individuals who participate using this service and 
who need special assistance, such as captioning of the conference 
call or other reasonable accommodations, should submit a request to 
the contact person listed above at least seven days prior to the 
meeting. If you experience any technical problems with the Web 
presentation tool or conference call, please e-mail 
IACCTechSupport@acclaroresearch.com.
    Members of the public who participate using the conference call 
phone number will be able to listen to the meeting but will not be 
heard. This phone call may end prior to or later than 1 p.m., 
depending on the needs of the Committee.
    To access the webinar on the Internet the following computer 
capabilities are required: (A) Internet Explorer 5.0 or later, 
Netscape Navigator 6.0 or later or Mozilla Firefox 1.0 or later; (B) 
Windows[reg] 2000, XP Home, XP Pro, 2003 Server or Vista; (C) Stable 
56k, cable modem, ISDN, DSL or better Internet connection; (D) 
Minimum of Pentium 400 with 256 MB of RAM (Recommended); (E) Java 
Virtual Machine enabled (Recommended)
    This meeting is being published less than 15 days prior to the 
meeting due to the timing limitations for completing the updating of 
the Annual Strategic Plan for Autism Spectrum Disorder Research.
    Information about the IACC is available on the Web site: https://www.iacc.hhs.gov.
    Meeting schedule subject to change.

    Dated: November 19, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-28284 Filed 11-24-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.